These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36883475)

  • 1. The next generation virus-like particle platform for the treatment of peanut allergy.
    Sobczak JM; Krenger PS; Storni F; Mohsen MO; Balke I; Reseviča G; Heath MD; Carreno Velazquez TL; Kramer MF; Scott CJW; Skinner MA; Zeltiņš A; Kündig TM; Vogel M; Bachmann MF
    Allergy; 2023 Jul; 78(7):1980-1996. PubMed ID: 36883475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine against peanut allergy based on engineered virus-like particles displaying single major peanut allergens.
    Storni F; Zeltins A; Balke I; Heath MD; Kramer MF; Skinner MA; Zha L; Roesti E; Engeroff P; Muri L; von Werdt D; Gruber T; Cragg M; Mlynarczyk M; Kündig TM; Vogel M; Bachmann MF
    J Allergy Clin Immunol; 2020 Apr; 145(4):1240-1253.e3. PubMed ID: 31866435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of antigen density and TLR ligands on preclinical efficacy of a VLP-based vaccine against peanut allergy.
    Krenger PS; Josi R; Sobczak J; Velazquez TLC; Balke I; Skinner MA; Kramer MF; Scott CJW; Hewings S; Heath MD; Zeltins A; Bachmann MF
    Allergy; 2024 Jan; 79(1):184-199. PubMed ID: 37815010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Ara h 2 with human-derived monoclonal antibodies prevents peanut-induced anaphylaxis in mice.
    Paolucci M; Wuillemin N; Homère V; Bieli D; Köhli A; Ballmer-Weber B; Waeckerle-Men Y; Pengo N; Kündig TM; Sonati T; Johansen P
    Allergy; 2023 Jun; 78(6):1605-1614. PubMed ID: 36704937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in mice.
    Liu Y; Sun Y; Chang LJ; Li N; Li H; Yu Y; Bryce PJ; Grammer LC; Schleimer RP; Zhu D
    J Allergy Clin Immunol; 2013 Jan; 131(1):213-21.e1-5. PubMed ID: 23199607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strain matters in mouse models of peanut-allergic anaphylaxis: Systemic IgE-dependent and Ara h 2-dominant sensitization in C3H mice.
    Paolucci M; Homère V; Waeckerle-Men Y; Wuillemin N; Bieli D; Pengo N; Sonati T; Kündig TM; Johansen P
    Clin Exp Allergy; 2023 May; 53(5):550-560. PubMed ID: 36629248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Single Monoclonal Antibody against the Peanut Allergen Ara h 2 Protects against Systemic and Local Peanut Allergy.
    Storni F; Cabral-Miranda G; Roesti E; Zha L; Engeroff P; Zeltins A; Cragg M; Vogel M; Bachmann MF
    Int Arch Allergy Immunol; 2020; 181(5):334-341. PubMed ID: 32155619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A murine model of peanut anaphylaxis: T- and B-cell responses to a major peanut allergen mimic human responses.
    Li XM; Serebrisky D; Lee SY; Huang CK; Bardina L; Schofield BH; Stanley JS; Burks AW; Bannon GA; Sampson HA
    J Allergy Clin Immunol; 2000 Jul; 106(1 Pt 1):150-8. PubMed ID: 10887318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 2S albumin allergens of Arachis hypogaea, Ara h 2 and Ara h 6, are the major elicitors of anaphylaxis and can effectively desensitize peanut-allergic mice.
    Kulis M; Chen X; Lew J; Wang Q; Patel OP; Zhuang Y; Murray KS; Duncan MW; Porterfield HS; W Burks A; Dreskin SC
    Clin Exp Allergy; 2012 Feb; 42(2):326-36. PubMed ID: 22288514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgE recognition patterns in peanut allergy are age dependent: perspectives of the EuroPrevall study.
    Ballmer-Weber BK; Lidholm J; Fernández-Rivas M; Seneviratne S; Hanschmann KM; Vogel L; Bures P; Fritsche P; Summers C; Knulst AC; Le TM; Reig I; Papadopoulos NG; Sinaniotis A; Belohlavkova S; Popov T; Kralimarkova T; de Blay F; Purohit A; Clausen M; Jedrzejczak-Czechowcz M; Kowalski ML; Asero R; Dubakiene R; Barreales L; Clare Mills EN; van Ree R; Vieths S
    Allergy; 2015 Apr; 70(4):391-407. PubMed ID: 25620497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peanut allergen inhibition prevents anaphylaxis in a humanized mouse model.
    Alakhras NS; Shin J; Smith SA; Sinn AL; Zhang W; Hwang G; Sjoerdsma J; Bromley EK; Pollok KE; Bilgicer B; Kaplan MH
    Sci Transl Med; 2023 Feb; 15(682):eadd6373. PubMed ID: 36753563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An unfolded variant of the major peanut allergen Ara h 2 with decreased anaphylactic potential.
    Starkl P; Felix F; Krishnamurthy D; Stremnitzer C; Roth-Walter F; Prickett SR; Voskamp AL; Willensdorfer A; Szalai K; Weichselbaumer M; O'Hehir RE; Jensen-Jarolim E
    Clin Exp Allergy; 2012 Dec; 42(12):1801-12. PubMed ID: 23181796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting CD22 on memory B cells to induce tolerance to peanut allergens.
    Hardy LC; Smeekens JM; Raghuwanshi D; Sarkar S; Daskhan GC; Rogers S; Nycholat C; Maleki S; Burks AW; Paulson JC; Macauley MS; Kulis MD
    J Allergy Clin Immunol; 2022 Dec; 150(6):1476-1485.e4. PubMed ID: 35839842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Food Allergy Herbal Formula-2 silences peanut-induced anaphylaxis for a prolonged posttreatment period via IFN-gamma-producing CD8+ T cells.
    Srivastava KD; Qu C; Zhang T; Goldfarb J; Sampson HA; Li XM
    J Allergy Clin Immunol; 2009 Feb; 123(2):443-51. PubMed ID: 19203662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic diversity between mouse strains allows identification of the CC027/GeniUnc strain as an orally reactive model of peanut allergy.
    Orgel K; Smeekens JM; Ye P; Fotsch L; Guo R; Miller DR; Pardo-Manuel de Villena F; Burks AW; Ferris MT; Kulis MD
    J Allergy Clin Immunol; 2019 Mar; 143(3):1027-1037.e7. PubMed ID: 30342892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice.
    Gregory JA; Shepley-McTaggart A; Umpierrez M; Hurlburt BK; Maleki SJ; Sampson HA; Mayfield SP; Berin MC
    Plant Biotechnol J; 2016 Jul; 14(7):1541-50. PubMed ID: 26801740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type B CpG oligodeoxynucleotides induce Th1 responses to peanut antigens: modulation of sensitization and utility in a truncated immunotherapy regimen in mice.
    Kulis M; Gorentla B; Burks AW; Zhong XP
    Mol Nutr Food Res; 2013 May; 57(5):906-15. PubMed ID: 23386314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peanut oleosins associated with severe peanut allergy-importance of lipophilic allergens for comprehensive allergy diagnostics.
    Schwager C; Kull S; Behrends J; Röckendorf N; Schocker F; Frey A; Homann A; Becker WM; Jappe U
    J Allergy Clin Immunol; 2017 Nov; 140(5):1331-1338.e8. PubMed ID: 28342912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ara h 2 and Ara 6 are the best predictors of severe peanut allergy: a double-blind placebo-controlled study.
    Kukkonen AK; Pelkonen AS; Mäkinen-Kiljunen S; Voutilainen H; Mäkelä MJ
    Allergy; 2015 Oct; 70(10):1239-45. PubMed ID: 26095653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lactobacillus buchneri S-layer as carrier for an Ara h 2-derived peptide for peanut allergen-specific immunotherapy.
    Anzengruber J; Bublin M; Bönisch E; Janesch B; Tscheppe A; Braun ML; Varga EM; Hafner C; Breiteneder H; Schäffer C
    Mol Immunol; 2017 May; 85():81-88. PubMed ID: 28212503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.